LEV SIMKHAYEV: Open Payments
NPI 1578563243 · EAST BRUNSWICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$968 in 38 payments from 11 companies in 2025. Trend: 2023 $1,350 · 2024 $1,634 · 2025 $968
Food & beverage: $968
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $403 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $261 |
| AstraZeneca Pharmaceuticals LP | 4 | $161 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| KYOWA KIRIN, INC. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| Lundbeck LLC | 1 | $15 |
Products named: XIFAXAN, FARXIGA, UBRELVY, VRAYLAR, LINZESS, CREON, Kerendia, REXULTI.
Industry payments across NJ — which companies pay providers there.
